Home/Filings/4/0001209191-21-007813
4//SEC Filing

Pernock David 4

Accession 0001209191-21-007813

CIK 0000827871other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 5:18 PM ET

Size

5.2 KB

Accession

0001209191-21-007813

Insider Transaction Report

Form 4
Period: 2021-02-02
Transactions
  • Award

    Common Stock

    2021-02-02+9,70054,625 total
Footnotes (1)
  • [F1]These shares were issued pursuant to a restricted stock unit ("RSU") award, each RSU representing a contingent right to receive one share of the Issuer's common stock. The shares issuable in respect of such RSUs shall vest with respect to 25% of the shares of common stock on each of the one, two, three and four-year anniversaries of February 2, 2021, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

Issuer

EAGLE PHARMACEUTICALS, INC.

CIK 0000827871

Entity typeother

Related Parties

1
  • filerCIK 0001471956

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:18 PM ET
Size
5.2 KB